UTHR - United Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

UTHR is currently covered by 15 analysts with an average price target of $351.84. This is a potential upside of $46.49 (15.23%) from yesterday's end of day stock price of $305.35.

United Therapeutics's activity chart (see below) currently has 135 price targets and 141 ratings on display. The stock rating distribution of UTHR is 82.93% BUY, 12.2% HOLD and 4.88% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 89.75% with an average time for these price targets to be met of 281.05 days.

Highest price target for UTHR is $600, Lowest price target is $302, average price target is $381.69.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 05-May-2025. First documented stock forecast 26-Dec-2014.

Currently out of the existing stock ratings of UTHR, 34 are a BUY (82.93%), 5 are a HOLD (12.2%), 2 are a SELL (4.88%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$425

$119.65 (39.18%)

$425

13 days ago
(05-May-2025)

13/16 (81.25%)

$126.3 (42.28%)

349

Hold

$348

$42.65 (13.97%)

$321

17 days ago
(01-May-2025)

8/9 (88.89%)

$54.15 (18.43%)

417

Buy

$350

$44.65 (14.62%)

$355

17 days ago
(01-May-2025)

7/9 (77.78%)

$56.15 (19.11%)

56

Buy

$314

$8.65 (2.83%)

$380

23 days ago
(25-Apr-2025)

6/7 (85.71%)

$22.62 (7.76%)

80

Sell

$314

$8.65 (2.83%)

$280

27 days ago
(21-Apr-2025)

1/3 (33.33%)

$29.75 (10.47%)

250

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is UTHR (United Therapeutics) average time for price targets to be met?

On average it took 281.05 days on average for the stock forecasts to be realized with a an average price target met ratio 89.75

Which analyst has the current highest performing score on UTHR (United Therapeutics) with a proven track record?

LIANA MOUSSATOS

Which analyst has the most public recommendations on UTHR (United Therapeutics)?

Liana Moussatos works at WEDBUSH and has 5 price targets and 7 ratings on UTHR

Which analyst is the currently most bullish on UTHR (United Therapeutics)?

Hartaj Singh with highest potential upside - $294.65

Which analyst is the currently most reserved on UTHR (United Therapeutics)?

Phil Nadeau with lowest potential downside - -$80.43

United Therapeutics in the News

3 Big Reasons to Love United Therapeutics (UTHR)

What a brutal six months it’s been for United Therapeutics. The stock has dropped 23.1% and now trades at $308, rattling many shareholders. This might have investors contemplating their next move. Given the weaker price action, is now the time to buy UTHR? Find out in our full research report, it’s free. Why Are We...

United Therapeutics First Quarter 2025 Earnings: Beats Expectations

United Therapeutics (NASDAQ:UTHR) First Quarter 2025 Results Key Financial Results Revenue: US$794.4m (up 17% from 1Q 2024). Net income: US$322.2m (up 5.1% from 1Q 2024). Profit margin: 41% (down from 45% in 1Q 2024). The decrease in margin was driven by higher expenses. EPS: US$7.18 (up from US$6.52 in 1Q 2024). AI is about to...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?